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Many genetic syndromes involve a facial gestalt that suggests a preliminary diagnosis to an experienced clinical
geneticist even before a clinical examination and genotyping are undertaken. Previously, using visualization and
pattern recognition, we showed that dense surface models (DSMs) of full face shape characterize facial dysmor-
phology in Noonan and in 22q11 deletion syndromes. In this much larger study of 696 individuals, we extend the
use of DSMs of the full face to establish accurate discrimination between controls and individuals with Williams,
Smith-Magenis, 22q11 deletion, or Noonan syndromes and between individuals with different syndromes in these
groups. However, the full power of the DSM approach is demonstrated by the comparable discriminating abilities
of localized facial features, such as periorbital, perinasal, and perioral patches, and the correlation of DSM-based
predictions and molecular ﬁndings. This study demonstrates the potential of face shape models to assist clinical
training through visualization, to support clinical diagnosis of affected individuals through pattern recognition, and
to enable the objective comparison of individuals sharing other phenotypic or genotypic properties.
Introduction
Many genetic syndromes involve craniofacial abnor-
malities (Gorlin et al. 2001). Indeed, the facial gestalt
often suggests a preliminary diagnosis before a clinical
examination and genotyping are undertaken (Winter
1996). A single facial feature, such as nose shape, may
even be sufﬁcient to suggest a particular syndrome. Pre-
viously, anthropometric and two-dimensional (2D) pho-
togrammetric studies have delineated craniofacial mor-
phology in a variety of syndromes (e.g., Allanson et al.
1985, 1993; Sharland et al. 1993; Allanson and Cole
1996; Allanson and Hennekam 1997; Ward et al. 2000).
Studies using 2D images have achieved an accuracy of
74% in intersyndrome discrimination comparing ﬁve
syndromic groups, each with 6–13 individuals (Loos et
al. 2003).
Recently, rapid, noninvasive three-dimensional (3D)
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imaging of the face surface has become available. The
clinical usability of 3D images is considerable because
the face is viewable from any angle and at closer prox-
imity than most children, or even adults, would tolerate.
Each image comprises a surface of 20,000 points and
2D images of facial appearance. Unlike 2D images, 3D
surfaces are robust to changes in illumination. It is pos-
sible to retrieve 3D data from a single 2D image, but
this requires standard lighting conditions or a previously
constructed lighting model.
3D face analysis using dense surface models (DSM)
has proven successful in delineating facial morphology
in Noonan syndrome (NS [MIM 163950]), 22q11 de-
letion syndrome (22q11DS [MIM 192430]), Bardet-
Biedl syndrome (MIM 209900) (Beales et al. 1997), and
Smith-Magenis syndrome (SMS [MIM 182290]), and
in discriminating well between controls and individuals
with NS and 22q11DS (Hammond et al. 2003a, 2003b,
2004). Full face surface analysis was employed in each
of these studies.
Craniofacial anomalies are associated with each of
the syndromes considered in this study. NS is a relatively
frequently occurring syndrome (∼1/2,000 live births)
characterized by short stature, heart defects, webbed
neck, chest deformity, mild learning disability, and char-
acteristic facial features. The facial phenotype in NS
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Figure 1 Facial phenotypes. A, Control; B, 22q11DS; C, NS; D, SMS; and E, WS. Each series is generated using a regression model of
age and the ﬁrst PCA mode of a DSM generated from faces in a homogeneous subgroup. The sequences do not use a common scale.
becomes less dysmorphic over time (Allanson et al.
1999). In ∼40%–50% of patients, the genetic cause
is a mutation in the protein tyrosine phosphatase
PTPN11, located at 12q24.1 (Tartaglia et al. 2001).
22q11DS is thought to be the most frequently occurring
microdeletion syndrome (1/4,000 live births), with a
highly variable phenotype that includes palatal and car-
diovascular anomalies, cognitive and behavioral ab-
normalities, and characteristic facial features (Scambler
et al. 1992). Mouse models and rare Japanesemutations
implicate haploinsufﬁciency for TBX1 as the main ge-
netic factor (Jerome and Papaioannou 2001; Yagi et al.
2003), although a role for neighboring genes has not
been ruled out. SMS is rare (1/25,000 live births) and
is usually caused by a microdeletion of ∼4 Mb at
17p11.2 (Greenberg et al. 1991). The phenotype is
characterized by infantile hypotonia, otolaryngolog-
ical anomalies, expressive language delay, oral motor
dysfunction, hearing loss, vision problems, short stat-
ure, small hands/feet (brachydactyly), scoliosis, devel-
opmental delay, expressed behavioral abnormalities
that include major sleep disturbance, and facial dys-
morphism. A limited number of patients have been
found to harbor a mutation in RAI1 instead of a mi-
crodeletion, suggesting thatRAI1 plays a signiﬁcant role
in the phenotype (Slager et al. 2003). Williams syn-
drome (WS [MIM 194050]), another neurodevelop-
mental disorder, occurs with a frequency of 1/20,000
live births. Affected individuals characteristically have
an outgoing personality, cognitive abnormalities, spe-
ciﬁc cardiovascular defects, hypercalcaemia, and hy-
peracusis. It is usually caused by a chromosomal mi-
crodeletion of ∼1.5 Mb at 7q11.23. Individuals with
WS have a characteristic facies (Morris et al. 1988).
In the present study, we extended previous morpho-
metric face analysis to SMS and WS and demonstrated
analogous delineation and discrimination abilities, us-
ing DSM-based methods. Furthermore, we show that if
we focus on smaller, more localized areas of the face,
we can achieve discrimination rates comparable to that
for the full face for all four syndromes. The discrimi-
nation analysis, in particular, identiﬁes which areas of
the face are more effective in distinguishing between
controls and individuals with a particular syndrome and
between syndromes. Finally, we demonstrate the full
power of localized 3D facial morphology by demon-
strating its correlation with the molecular analysis of
four individuals with an initial, putative diagnosis of
WS.
Subjects and Methods
Subject Recruitment and Data Capture
The controls, 185 individuals younger than 20 years
and 132 20 years and older, were recruited as volunteers
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Figure 2 Illustration of the three localized face patches used in
the discrimination testing. Left, periorbital; center, perinasal; and right,
perioral.
or as unaffected siblings and parents. Individuals with
a syndrome were recruited either at family support meet-
ings and international conferences in Europe and the
United States or through clinical collaborators. Before
the study, all affected patients had been given a clinical
diagnosis of one of the four syndromes (NS, 22q11DS,
SMS, or WS). Patients were included in the study if they
had been cytogenetically proven. They were excluded if
judged by experienced dysmorphologists (J.E.A., R.H.,
K.M., M.P., A.C.M.S., and I.K.T.) to not have the facial
features of the syndrome for which they had a putative
diagnosis. Thus, the individuals studied comprised 696
controls and patients, all white.
The affected individuals consisted of 80 individuals
with NS, 54 with SMS, 115 with 22q11DS, and 130
with WS. Of these, 16 patients with NS were known to
have a PTPN11 mutation. Positive FISH tests were
known for 46 of the SMS subset, 112 of the 22q11DS
subset, and 109 of the WS subset.
The study was approved by the University College
London Hospital Research Ethics Committee, and par-
ticipants, parents, or guardians gave informed written
consent (JREC 00/E042).
Facial Phenotypes
In patients with 22q11DS (ﬁg. 1b), the face is some-
what subtle and not always obviously different from
average. In general, one of the most striking features is
increased nasal height, with relatively narrow nares and
nasal base but with fullness above the tip of the nose.
Eyes are often upslanted, with hooded lids. Ears may be
cupped or unusual in shape. With increasing age, the
exaggerated length of the nose is less obvious, but the
nose remains unusual and somewhat tubular, with some
broadening at the root and narrowing at the base. Full-
ness remains above and lateral to the tip.
The young child with NS (ﬁg. 1c) has a tall forehead
with some narrowing at the temples, wide-spaced and
downslanting eyes, sometimes with droopiness of the lid,
a short, broad nose, a well-grooved upper lip with full
lips in a cupid’s bow conﬁguration, a small chin, and
low-set, posteriorly angulated ears. Over time, the fore-
head becomes less dominant, while the chin becomes
longer, leading to an inverted triangular facial shape. As
the nose lengthens, it appears less broad. Flattening of
the mid-face is probably apparent at all ages but may
be more obvious in older individuals, when fullness of
the cheeks is less prominent.
In patients with SMS (ﬁg. 1d), the facial appearance
can be quite subtle in early life but becomes more dis-
tinctive with age. One characteristic feature is the un-
usual shape of the upper lip, where the philtrum is “trap-
ezoidal” and the philtral pillars appear thickened and
everted. In proﬁle, the eversion of the upper lip mirrors
the protrusion of the tip of the nose. The face becomes
increasingly square and “pugnacious” because of mid-
face hypoplasia, especially in the older individual. The
brow is heavy, accentuating deep, close-set eyes that are
often upslanting. Synophrys is usually present. Over
time, the jaw becomes broader and more prominent and
prognathic relative to the upper face.
For WS (ﬁg. 1e), in the young child, features include
broad forehead, bitemporal narrowing, depressed nasal
root, periorbital fullness, full nasal tip, ﬂattening of the
mid-face, long philtrum, full lips, wide mouth, and full
cheeks with a small jaw. With age, in addition to vertical
lengthening of the face, there is a more gaunt appear-
ance, less fullness to the cheeks, a prominent supra-
orbital ridge, narrow and fairly prominent root of the
nose, continuing ﬂattening of the mid-face, more notable
widening of the mouth, and full lips.
3D Image Capture and Preparation
3D face images were captured with commercial pho-
togrammetric devices (3dMD and Surﬁm). Depending
on the system used, the captured face surface contained
4,000–20,000 3D points. Each image was manually an-
notated with 21 3D landmarks: left and right endocan-
thion, exocanthion, palpebrale superius, palpebrale in-
ferius, crista philtrum, cheilion, alare and lower lip third;
nasion, pronasale, subnasale, labiale superius, and gna-
thion. For each of the syndrome-control and intersyn-
drome comparisons, 20 randomly generated 90%–10%
training-test set pairs, stratiﬁed with respect to affected
and unaffected totals, were generated from the appro-
priate set of landmarked face surfaces. Each training set
was used to generate a DSM of the full face and localized
periorbital, perinasal, and perioral patches (ﬁg. 2).
Following manual landmarking, collections of face
surfaces were used to compute DSMs. A DSM is the set
of modes resulting from a principal component analysis
(PCA) of the residuals between a collection of “training”
surfaces and their mean with the use of thousands of
densely corresponded points. A more detailed descrip-
tion of the technique is provided elsewhere (Hutton et
al. 2003; Hammond et al. 2004). Typically, ∼100 PCA
modes are sufﬁcient to cover 99% of shape variation in
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a DSM of the full face. This subset of modes can be
used to synthesize each face in the original training set.
Thus, a surface originally represented by 20,000 points,
or 60,000 variables, can be reconstructed using a
weighted sum of ∼100 modes. In the multidimensional
“face-space” deﬁned by the vectors of modes, the dif-
ference between two faces is computed as the Euclidean
distance between the vectors representing them.
Delineation and Discrimination of Face Shape
For the discrimination testing, three pattern recogni-
tion algorithms—closest mean (CM), linear discriminant
analysis (LDA), and support vector machines (SVM)—
were used to classify the unseen test faces (Vapnik 1995).
With CM, the average faces are computed for the control
and syndrome subgroups in the training set, and each
unseen test face is classiﬁed according to which average
it is closer to. For LDA, the goal is a linear combination
of PCA modes that exhibits the largest difference in the
subgroup means relative to the within-group variance.
SVM, or large margin classiﬁers, focus on individual
cases in the overlap of the subgroups to be classiﬁed that
help to deﬁne a separating surface with the largest mar-
gin between the subgroups.
The DSM representations of the faces in the 90%
training set were presented to the three classiﬁcation al-
gorithms as a set of vectors to produce discrimination
models for classifying the 10% test set unseen. Rather
than selecting one of the associated sensitivity-speciﬁcity
results arising from the 20 training-unseen test set pairs
as representative (e.g., the one with the highest sensitiv-
ity), we constructed a receiver operating characteristics
(ROC) curve for each split. The underlying distribution
of position relative to the discriminating plane for CM
discrimination has been veriﬁed as approximately nor-
mal for both the control and affected subgroups for the
four syndromes considered. For each syndrome-control
pair, and for the CM, SVM, and LDA pattern recog-
nition algorithms, the 20 ROCs have been summarized
by their mean. The ROC plots are available as additional
material on the associated Eastman Dental InstituteWeb
site.
For each ROC curve, we estimated the equal error
rate, which is the point on the ROC curve where true
positive and false positive rates sum to unity. For each
algorithm, the classiﬁcation performance of the 20 sep-
arate 90%–10% splits was summarized as the average
of the equal error rates derived from the associated ROC
curves. Henceforth, we refer to this as the “classiﬁcation
performance” and express it in terms of the correspond-
ing true positive rate. For algorithms such as SVM, dif-
ferent model building parameter values and different
kernel functions were used for training. The classiﬁca-
tion performance quoted in such instances is the best
average for the different parameter combinations
considered.
When evaluating the facial phenotype of particular
individuals, we used the same models generated from
the training sets to classify each individual’s face, or face
patch, unseen. This enabled an average classiﬁcation po-
sition and 95% CIs to be estimated for each subject with
respect to CM classiﬁcation.
Dynamic morphs of faces and face patches varying
between different control and syndromic group pairings
provide an excellent delineation of shape differences.
During the generation of the dense correspondence of
points across a set of faces, it is necessary to trim back
the surface to an area that is common to each surface
in the set. Because the earlier face-scanning systems did
not capture ears well, ears do not always feature in the
DSMs generated. Although ear shape and position are
important aspects in the gestalt recognition of faces, the
classiﬁcation performance based on face surfaces lacking
ears are generally very accurate (typically 185%). There-
fore, for DSMs computed solely for the visualization of
facial form (see ﬁg. 1), a subset of face scans with good
ear coverage was selected and six additional landmarks
were added to each face: preaurale and otobasion in-
ferius for each ear and left and right frontotemporale.
The latter two landmarks, even though invariably pre-
sent in a captured face surface, were not used in the
generation of DSMs for discrimination testing because
of the unreliability inherent in their manual placement.
Clinical Summary of Four Adults with a Putative
Diagnosis of WS
Four adult patients were selected as representing a
broad spectrum of facial phenotypes in WS. Patient 1
did not appear to have obvious facial features of WS,
whereas patient 2 had most of the features, relatively
strongly. The face of patient 3 was thought to be typical,
whereas patient 4 had some features but, overall, was
atypical.
Patient 1 was referred as possibly having WS, mainly
because of neonatal hypercalcaemia and developmental
delay, but without strong WS facial morphology. He had
no heart problems, and adult height was 176.1 cm. Pa-
tient 2 had problems in the neonatal period with failure
to thrive. There was documented hypercalcaemia and
constipation. He had no structural cardiac defect and
motor milestones were delayed. Diagnosis was based on
the typical personality and facial features. Patient 3 also
had problems in the neonatal period with failure to
thrive. A diagnosis was not suggested at this stage and
there is no documented hypercalcaemia. There was no
cardiac anomaly, but hyperacusis and learning delay
were recorded. Diagnosis was based on personality and
facial features typical for WS. Patient 4 had no docu-
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Figure 3 Portrait and proﬁle views of average faces for the controls and for each syndrome (not to a common scale). A, 22q11DS; B,
Control; C, SMS; D, WS; E, Control adults; F, NS; G, WS adults. Face shape differences are better evaluated by viewing the dynamic morphs
on the Eastman Dental Institute Web site.
mented hypercalcaemia but was treated for bilateral in-
guinal herniae and developed hyperacusis later on. De-
velopmental milestones were delayed. Photographs
showed typical facial WS features in the early years, and
a clinical diagnosis of WS was made at age 8.
Molecular Analysis
FISH was performed using a commercially available
probe (ONCOR) to detect the 7q11.23 chromosome
deletion. Microsatellite genotyping was performed to
detect hemizygosity at 7q11.23 with the use of eight
polymorphic markers (Ge´ne´thon) mapping to the mi-
crodeleted region (Foster et al. 1993; Gyapay et al.
1994). PCRs were performed in mixtures containing 100
ng of genomic DNA, 750 mmol of each dNTP, 1ml 10#
PCR buffer at 37 mM Mg2, 5 pmol of each primer, and
0.25 units of Taq polymerase (BCL) in a ﬁnal volume
of 10 ml. Samples were processed through standard PCR
conditions: denaturation at 94C for 2 min, followed
by 27 cycles of 93C for 50 s, 58C for 50 s (except
D7S2490 at 60C), and 72C for 1 min, with a ﬁnal
extension time of 5 min at 72C. The PCR products
were run on an 8% polyacrylamide gel (acrylamide:
N,N′methylene bisacrylamide 19:1, 300V, 2 h 15 min),
and the alleles were visualized by silver staining.
Results
Delineation of Average Face Shape Differences and
Visualization of Average Growth
DSMs generated from a large set of children and
young adults generally have a ﬁrst principal component,
or mode, that reﬂects overall face size and that correlates
well with age, a typical Pearson product moment cor-
relation coefﬁcient being 0.9. Hence, the ﬁrst mode of
such a DSM is an approximation of facial growth. Sep-
arate DSMs for children’s faces were computed for the
control subset and for each of the four syndromes with
the use of subsets of face scans for which there was good
ear coverage. As described above, additional landmarks
were added to these faces before the DSMs were com-
puted. By morphing and simultaneously rotating the
mean face, using a regression of age against mode 1 for
each of these DSMs, we generated ﬁve sequences of facial
growth (ﬁg. 1).
Using the same subsets of images with good ear cov-
erage and the extra landmarks, we computed four fur-
ther DSMs for each of the control-syndrome compari-
sons. These models were used to produce static portrait
and proﬁle views of the average faces of the control
subgroup and each group of individuals with a syndrome
(ﬁg. 3). Comparison of the static average faces provides
further delineation of the facial differences. Besides these
static growth sequences and averages, more revealing
dynamic morphs can be viewed in the additional ma-
terial provided online at the Eastman Dental Institute
Web site.
Discrimination Testing
The results of the unseen discrimination testing using
the three pattern recognition algorithms (CM, SVM, and
LDA), are summarized in table 1. The discrimination
performance of the full face for the 10 pairwise control-
syndrome and syndrome-syndrome comparisons for
children ranges from 87% to 98%, depending on the
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Table 1








COMPARISON Face Eyes Nose Mouth Face Eyes Nose Mouth Face Eyes Nose Mouth
Childrena:
WS vs. Control 94 93 93 88 96 93 93 89 98 93 93 89
SMS vs. Control 87 89 94 88 88 93 94 89 91 92 94 86
NS vs. Control 94 89 81 83 94 92 82 86 94 89 82 83
22q11DS vs. Control 91 81 85 83 94 83 87 85 90 83 85 84
WS vs. NS 88 88 88 88 91 89 88 88 92 88 88 88
WS vs. SMS 88 91 90 88 94 95 95 88 94 96 94 88
WS vs. 22q11DS 89 90 89 89 91 94 96 91 90 95 94 90
NS vs. SMS 88 88 80 80 94 88 80 86 97 89 80 80
NS vs. 22q11DS 91 91 91 77 91 93 91 79 91 93 91 76
SMS vs. 22q11DS 91 91 91 82 91 93 92 85 90 91 91 85
Adultsb:
WS vs. Control 92 92 92 92 100 95 92 94 100 98 95 95
NOTE.—Each row of the table shows the discrimination rates for 1 of 10 pairwise comparisons of a control group and 4
syndrome populations. The ﬁrst four columns show the classiﬁcation performance for four face areas (full face, eyes patch, nose
patch, and mouth patch) for the CM algorithm. The next four and the ﬁnal four columns show the corresponding results for
the SVM and LDC algorithms, respectively.
a Control ( ); WS ( ); NS ( ); SMS ( ); and 22q11DS ( ).np 185 np 85 np 80 np 54 np 115
b Control ( ) and WS ( ).np 132 np 45
algorithm, with LDA and SVM giving the best overall
performance. Although the CM algorithm is relatively
unsophisticated, its classiﬁcation accuracy is close to that
of LDA and SVM.
The control-syndrome comparisons in table 1 were
also visualized in facial cartoons for more transparent
interpretation (ﬁg. 4). In each cartoon, the outside ellipse
represents the full face and the inner ellipses represent
the three face patches: periorbital, perinasal, and per-
ioral. The darkness of the shading of each ellipse reﬂects
the classiﬁcation performance, with black representing
the lowest value in the control-syndrome comparisons
and white representing a classiﬁcation performance of
100%. Thus, the darker the shading, the lower the clas-
siﬁcation performance. For example, the perfect discrim-
ination between adult control faces and those of indi-
viduals with WS, an average classiﬁcation performance
of 100% (table 1), is reﬂected in the large ellipse being
totally unshaded. The poorest classiﬁcation perfor-
mance, for the control-NS classiﬁcation using the peri-
nasal patch, is shown in black. Table 1 also summarizes
the classiﬁcation performance for each syndrome-syn-
drome comparison.
It is possible to illustrate face shape difference between
controls and individuals with a syndrome by comparing
an exaggeration of the mean face of a syndrome group
with that of the mean control. In the discrimination anal-
ysis using CM, the relative positions of the mean control
and syndrome group faces are normalized to the interval
[1,1], and the position of a face along this interval,
relative to the bisecting plane at its origin, determines
its classiﬁcation. The mean syndromic face, one unit dis-
tant from the origin, can be exaggerated to a position
two units away. Typically, this is close to those individ-
uals whose faces are the most dysmorphic. The surfaces
of the faces of the syndrome mean exaggerated in this
way and the mean control are then registered using an
iterative closest-point procedure. The distance between
the two registered surfaces is used to color code regions
of the exaggerated face, with red showing those areas
furthest from and inside the mean control face surface,
and blue showing those areas furthest from and outside
the mean control surface. Other colors, as in the accom-
panying scales, show regions of intermediate position.
Figure 5 includes such “thermal” depictions of surface
differences for NS (top left), SMS (top right), 22q11DS
(bottom left), and WS (bottom right).
A 10-fold cross-validation has also been undertaken
for full face discrimination testing with the CM classi-
ﬁcation of the combined syndrome subgroups. With the
use of randomized 90%–10% training-test set pairs
and maintaining stratiﬁcation (proportional representa-
tion) across the four syndrome subgroups, the classiﬁ-
cation of a random collection of 320 affected children
resulted in 35 misclassiﬁcations. Thus, the overall ac-
curacy across all syndromes was 89%. The correspond-
ing correct classiﬁcation rates for each syndrome were
as follows: NS (89%), SMS (78%), 22q11DS (89%),
and WS (96%).
In the set of 185 controls used for each syndrome-
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Figure 4 Alternative, cartoon representations of the control-syndrome discrimination performance in table 1. Each large ellipse represents
the face, and the smaller inner ellipses represent the periorbital, perinasal, and perioral patches. The darkness of the shading of each ellipse
reﬂects the classiﬁcation performance, with black representing the lowest of the control-syndrome entries (at 81%), and white the highest. Thus,
the darker the shading, the lower the classiﬁcation performance.
based analysis of children’s faces, 29 families were rep-
resented with 2 siblings. No siblings were included in
the adult data sets. To test sibling exclusion, we removed
37 siblings, leaving a control set of 148 unrelated chil-
dren. We recomputed the discrimination performance
for the unrelated controls and children with WS. The
classiﬁcation performance of the CM algorithm re-
mained at 94%, whereas those of the LDA and SVM
algorithms were reduced by 2%, from 98% to 96% and
from 96% to 94%, respectively. We concluded that the
removal of siblings makes little difference to the clas-
siﬁcation performance in WS. Similar calculations can
be performed for the other entities described here.
3D Facial Analysis of Four Unconﬁrmed WS Patients
Figure 6 contains a background scatterplot of all 20
unseen, randomly generated test sets used to determine
the classiﬁcation performance of the nearest mean al-
gorithm for adult controls and adults with WS. The ver-
tical axis measures age in years. The horizontal axis
measures the position of a face relative to the control
and WS averages normalized to the interval [1,1], with
the average adult control face for the corresponding
training set at1 and the average face of the adults with
WS at 1. The Y-axis can be thought of as the classi-
ﬁcation line. Thus, the scatterplot reﬂects the overall,
and highly accurate, discriminating ability of the nearest
mean classiﬁcation algorithm for the full-face compar-
ison of adult controls and adults with WS.
The average position of each selected adult’s face rel-
ative to the control and WS mean faces over the 20
training sets was added to the background scatterplot.
These average positions are also shown with 95% CIs.
The same calculation of average positions relative to the
two means was repeated for the 20 training sets used in
the localized face patch analyses (ﬁg. 7). Figure 7 shows
the average positions and CIs for the same four adults
for each face patch but without a background scatter of
the unseen test set classiﬁcation as in ﬁgure 6.
Molecular Genotypes of Four Adults with Putative WS
Diagnosis
The molecular analysis is summarized in ﬁgure 8. Mo-
lecular diagnosis of WS by FISH testing identiﬁed a
hemizygous deletion at the elastin locus in patients 2, 3,
and 4. This was conﬁrmed by microsatellite genotyping
using polymorphic markers in the region. The classic
WS deletion includes the markers D7S489B–D7S1870,
but deﬁnition of the deletion size with the use of micro-
satellite mapping is limited by their polymorphic status
in a given family and is generally used in diagnostic
situations where FISH analysis is not possible or the
results are unclear.
Patients 2 and 3 were deleted for the paternally in-
herited copy of the elastin gene and the microsatellite
D7S2472 (distal to theCYLN2 gene), but uninformative
for the ﬂanking markers. Patient 4 was more informa-
tive, showing deletion of the maternally inherited copy
of the elastin allele as well as the microsatellite markers
in the genomic region spanning the genes FZD9 to
GTF2I. In contrast, patient 1 was not deleted for any
of the informative microsatellite markers tested in the
region (no sample was available for FISH analysis), sug-
gesting that he does not have WS.
Comparison of 3D Face Analyses and Genotype of
Adults with Putative WS Diagnosis
In patients 2 and 3, who ﬁt the WS facial phenotype
well, the molecular results identiﬁed a hemizygous de-
letion at 7q11.23. In the case of patient 4, the facial
gestalt does not ﬁt the classic WS phenotype. In the
separate DSM analysis of his features, he showed pos-
itive for the full face, eyes, and nose, but negative for
the mouth—the latter being consistent with a relatively
short philtrum for WS. Molecular analysis conﬁrmed
that he did, indeed, have a microdeletion. Since patient
4 has been categorized as having less classic dysmorph-
ism, he is undergoingmore detailed analysis to determine
if there are any differences at the molecular level. Finally,
in patient 1, the positive result for themouth is consistent
with a relatively long philtrum. However, for the face,
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Figure 5 Comparison of exaggerated average faces of syndromic groups with the average control. Upper left, NS; upper right, SMS;
lower left, 22q11DS; and lower right, WS. The color coding reﬂects the distance between the compared face surfaces. Red, regions most distant
and internal to the mean control face. Blue, regions most distant and external. Other colors shown in the scales identify intermediate positions.
Each ﬁgure has its own quantitative scale and also uses a different “zero” color for regions where the two surfaces coincide. It is not possible
to employ a single scale to show both subtle and gross surface differences. Therefore, care must be taken in their interpretation.
eyes, and nose analysis, he was not categorized as having
WS, which was conﬁrmed by the lack of a gross genomic
deletion in the critical region.
Discussion
Clinical geneticists often refer to facial differences and
features that offer clues to diagnosis. Articulating those
differences can be challenging, especially if an individ-
ual’s face shows a mild facial phenotype or if morpho-
logical characteristics are manifest in only part of the
face. Our results suggest that static and dynamic visu-
alizations derived from DSMs of 3D images can delin-
eate dysmorphic features well and, hence, may be useful
in the training of clinical geneticists and pediatricians.
Being able to test the discriminating ability of speciﬁc
regions is useful for anatomical regions of particular
interest to clinicians or for tissues identiﬁed as being
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Figure 6 Average classiﬁcation position between control and WS mean faces, for faces of four selected adults with WS for 20 DSMs
computed from the randomized 90%–10% splits used to calculate average discrimination performance. CIs of 95% have been added to the
average classiﬁcation position. The background scatterplot shows the classiﬁcation position of the 20 unseen test sets for the relevant DSM.
The vertical broken lines mark the position of the two means at 1 and 1 respectively. All other positions are normalized to [1,1].
developmentally important, perhaps in related mouse
studies. In-depth analysis to identify the discriminating
features associated with each syndrome has highlighted
differences in the discrimination performance of local-
ized patches of the face (periorbital, perinasal, and per-
ioral). It can be seen from the face discrimination car-
toons (ﬁg. 4) or from table 1 that for the WS-control
comparison for children, the nose and eyes patches dis-
criminate very well, almost as well as the full face. The
mouth patch discriminates less well. By comparison, the
adult results for the mouth are much better, which is
not surprising, since this is a feature that is exaggerated
with age. The documented increase in typical features
of WS in later life underlies the extremely high discrim-
ination rates for adults, especially for the full face at or
close to 100%.
The NS-control discrimination was noticeably poorer
for the mouth and nose patches and was not much better
for the eyes patch. The photogrammetric scanners used
in this study are known to have problems capturing wet
surfaces and hair. Therefore, less accurate capture of
eye surfaces, eyelashes, and eyebrows may diminish fa-
cial differences, such as downward sloping palpebral
ﬁssures and ptosis of the eyelids, that are obvious to
the naked eye. We conclude that consideration of the
entire face, the overall gestalt, is much more important
in NS than in, say, WS.
The most intriguing of the discrimination results are
those for SMS. The eyes and nose patches perform rea-
sonably well, considering the comparatively small num-
ber of affected individuals included. The unusual shape
of the upper lip frequently features in the description
of the gestalt for SMS and can be easily observed in the
static comparison of average faces (ﬁg. 3) or, more dra-
matically, in the dynamic morph provided in the ad-
ditional material. However, the eyes and nose patches
discriminate at a signiﬁcantly higher level. For the eyes
patch, the midfacial hypoplasia and ﬂatness of the nasal
bridge may be the key. The nose patch overlaps at the
nasal bridge but also reﬂects the signiﬁcant upward and
backward deﬂection of the subnasale, often resulting in
a hidden columella and concave undersurface to the
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Figure 7 Average classiﬁcation of four selected individuals with WS for the three localized face patches
nose. The poorer performance of the full face is similar
to that for the mouth patch. One possible explanation
may be due to the nose and eyes already discriminating
well. So, the increase in the area examined to the full
face, and the concomitant increase in the number of
variables analyzed, occur without an increase in the
number of training examples to generate a better dis-
criminating model. However, such an explanation may
not sit well with the WS discrimination performance,
where the eyes and nose patches also do well.
Given the relatively subtle facial phenotype in
22q11DS, the better performance of the full face over
the nose and eyes was expected. The narrow mouth and
shallow groove between the lower lip and chin (the
latter not usually included in the gestalt description)
may explain the reasonable perioral performance.How-
ever, lip tension and facial expression in subjects with
22q11DS cannot be discounted as an inﬂuencing factor.
Even so, the full face discriminates at a satisfactory level.
Since our ﬁrst 3D face-based analysis of NS and
22q11DS, more accurate laser and photogrammetric
scanners have become available and more families have
been recruited. As a result, the previous visualizations
of face shape differences (Hammond et al. 2003b) have
been dramatically improved, as have the discrimination
results for the full face. Because the recruitment of af-
fected individuals continues to be relatively low, male
and female patients have had to be combined in the
delineation modeling and discrimination testing. How-
ever, as recruitment improves, separation of the popu-
lations by both gender and ﬁner chronological steps will
be possible and should further improve the results.
The potential of using DSMs of face shape to aid
clinical diagnosis was also highlighted in this study. The
syndrome-syndrome discrimination results are sufﬁ-
ciently accurate to encourage the use of DSM-based
techniques for screening individuals simultaneously for
a range of facial phenotypes. The molecular analysis of
the four patients, three with clinical descriptions sug-
gestive of WS, conﬁrms the accuracy of the predictions
made by the WS adult models and supports their use
in a diagnostic environment. Moreover, such accuracy
in pinpointing similarities and differences in facial mor-
phology suggests that DSMs may have a future role in
the investigation of patient subgroups who share a phe-
notypic or genotypic description. 3D dense surfacemod-
eling allows objective grouping of affected individuals
into those who ﬁt the classic facial phenotype, those
who clearly do not, and those who justify more detailed
molecular mapping, such as microarray comparative ge-
nome hybridization, to investigate genotype-phenotype
correlations.
In the discrimination testing, particular localized
regions of the face were used. From the discrimination
analysis of the whole face surface, it is also possible to
derive and visualize by color coding the parts of the face
that differ the most. Careful examination of the “ther-
mal” images shown in ﬁgure 5 provides insight into the
origins of face shape difference. For example, the ﬁgure
panel for WS (bottom right) shows that the prominence
around the mouth is partly a real prominence in the
premaxilla, maxilla, and mandible. In part, however, it
also arises from hypoplasia of the malar region. Simi-
larly, the prominent supraorbital arches are, in part,
caused by true hyperplasia of that area, but also, in
part, by hypoplasia of the superior parts of the forehead.
In conclusion, dense surface modeling of the full face
and of localized facial morphology supports clinical
training and the screening of diagnostic options and can
contribute to phenotype-genotype analysis. The diag-
nosis of WS may not be a challenge to experienced
clinicians, but objective computer-based face shape
analysis is likely to be particularly helpful in evaluating
partial deletion patients and understanding facial
change over developmental time, in situations where
there is a lack of local clinical expertise or a lack of
funds and/or facilities for genetic testing or where no
appropriate genetic test exists.
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